英特集团(000411) - 2021 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2021 was CNY 6,453,585,764.63, representing a 14.39% increase compared to CNY 5,641,712,419.14 in the same period last year[8] - Net profit attributable to shareholders was CNY 41,224,972.28, up 24.19% from CNY 33,195,961.68 year-on-year[8] - The net profit after deducting non-recurring gains and losses was CNY 44,896,900.56, reflecting a significant increase of 47.10% from CNY 30,521,804.24 in the previous year[8] - The basic earnings per share rose to CNY 0.1656, a 24.23% increase from CNY 0.1333 in the same quarter last year[8] - Operating profit increased by 42.01% to ¥131,384,671.87, driven by higher operating revenue leading to increased gross profit[19] - Net profit rose by 30.39% to ¥92,263,855.36, attributed to the increase in operating revenue[19] - Total operating revenue for Q1 2021 reached CNY 6,453,585,764.63, an increase of 14.4% compared to CNY 5,641,712,419.14 in Q1 2020[52] - Total operating costs for Q1 2021 were CNY 6,318,587,388.65, up from CNY 5,545,990,767.92 in the same period last year, reflecting a growth of 13.9%[53] - Operating profit for Q1 2021 was CNY 131,384,671.87, compared to CNY 92,515,423.86 in Q1 2020, representing a year-over-year increase of 42.0%[53] - Net profit for Q1 2021 amounted to CNY 92,263,855.36, a rise from CNY 70,758,854.54 in Q1 2020, indicating a growth of 30.4%[53] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 12,664,322,711.29, marking a 12.57% increase from CNY 11,250,269,584.65 at the end of the previous year[8] - Total assets as of March 31, 2021, were CNY 12,664,322,711.29, compared to CNY 11,250,269,584.65 at the end of 2020, marking an increase of 12.6%[47] - Total liabilities increased to CNY 9,256,985,480.37 in Q1 2021 from CNY 8,044,420,490.32 in Q1 2020, reflecting a growth of 15.1%[47] - Shareholders' equity totaled CNY 3,407,337,230.92 as of March 31, 2021, up from CNY 3,205,849,094.33 at the end of 2020, representing a growth of 6.3%[47] - The company's current assets totaled approximately 11.29 billion yuan, up from 10.04 billion yuan at the end of 2020[44] - Short-term borrowings increased to approximately 2.59 billion yuan as of March 31, 2021, compared to 2.05 billion yuan at the end of 2020[45] - The company's inventory as of March 31, 2021, was approximately 2.81 billion yuan, an increase from 2.60 billion yuan at the end of 2020[44] Cash Flow - The company's cash flow from operating activities showed a net outflow of CNY -1,270,433,692.30, compared to CNY -1,139,928,630.41 in the same period last year[8] - Cash received from operating activities decreased by 34.53% to ¥142,156,276.11, mainly due to government funding for pandemic-related purchases received in the previous year[22] - Cash inflow from financing activities increased by 35.04% to ¥2,115,431,989.68, primarily due to funds received from issuing convertible bonds[22] - Cash outflow for repaying debts increased by 59.28% to ¥975,559,233.23, reflecting higher payments for short-term loans[22] - The net cash flow from operating activities was negative at CNY -1,270,433,692.30, worsening from CNY -1,139,928,630.41 in the previous year[61] - Cash inflow from operating activities totaled CNY 5,686,090,061.96, compared to CNY 5,407,469,056.05, an increase of 5.2%[60] - Cash outflow from operating activities was CNY 6,956,523,754.26, up from CNY 6,547,397,686.46, reflecting an increase of 6.2%[61] - The net cash flow from investing activities was -124,160,738.85 yuan, compared to -471,087.40 yuan in the previous period, showing a significant increase in cash outflow[65] - Cash inflow from financing activities totaled 594,811,320.75 yuan, with a net cash flow from financing activities of 591,024,791.90 yuan, a substantial increase compared to -11,506.69 yuan in the previous period[65] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 35,643, with the top ten shareholders holding significant stakes in the company[11] - The net profit attributable to the parent company was CNY 41,224,972.28, up from CNY 33,195,961.68, reflecting a growth of 24.3%[54] - The total comprehensive income for the first quarter was CNY 92,251,761.37, compared to CNY 77,222,439.46, indicating an increase of 19.5%[54] - Basic earnings per share rose to CNY 0.1656 from CNY 0.1333, representing a growth of 24.0%[54] Investments and Projects - The company plans to issue up to ¥600 million in convertible bonds as approved by the board, aiming to enhance its capital structure[23] - The company has invested CNY 64.45 million in the Shaoxing (Shangyu) pharmaceutical industry center project, with CNY 54.07 million being a reimbursement of previously invested funds[32] - The company plans to collaborate with a state-owned investment group to develop a smart health center project, with an estimated construction area of over 27,000 square meters[4] - The company’s subsidiary, Yinte Pharmaceutical, is set to transfer a property valued at CNY 96.94 million, with a minimum transfer price of 90% of the assessed value[4] Compliance and Regulations - The company reported no instances of non-compliance with external guarantees during the reporting period[38] - The first quarter report was not audited[74] - The company has not made any adjustments related to the new leasing standards for prior comparative data[73]